FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3157158131> ?p ?o ?g. }

• W3157158131 endingPage "720" @default.
• W3157158131 startingPage "710" @default.
• W3157158131 abstract "Abstract Human challenge trials (HCTs) are a potential method to accelerate development of vaccines and therapeutics. However, HCTs for COVID‐19 pose ethical and practical challenges, in part due to the unclear and developing risks. In this article , we introduce an interactive model for exploring some risks of a severe acute respiratory syndrome coronavirus‐2 (SARS‐COV‐2) dosing study, a prerequisite for any COVID‐19 challenge trials. The risk estimates we use are based on a Bayesian evidence synthesis model which can incorporate new data on infection fatality risks (IFRs) to patients, and infer rates of hospitalization. The model estimates individual risk, which we then extrapolate to overall mortality and hospitalization risk in a dosing study. We provide a web tool to explore risk under different study designs. Based on the Bayesian model, IFR for someone between 20 and 30 years of age is 15.1 in 100,000, with a 95% uncertainty interval from 11.8 to 19.2, while risk of hospitalization is 130 per 100,000 (100–160). However, risk will be reduced in an HCT via screening for comorbidities, selecting lower‐risk population, and providing treatment. Accounting for this with stronger assumptions, we project the fatality risk to be as low as 2.5 per 100,000 (1.6–3.9) and the hospitalization risk to be 22.0 per 100,000 (14.0–33.7). We therefore find a 50‐person dosing trial has a 99.74% (99.8–99.9%) chance of no fatalities, and a 98.9% (98.3–99.3%) probability of no cases requiring hospitalization." @default.
• W3157158131 created "2021-05-10" @default.
• W3157158131 creator A5010975997 @default.
• W3157158131 creator A5038415036 @default.
• W3157158131 creator A5076793709 @default.
• W3157158131 creator A5087563394 @default.
• W3157158131 date "2021-05-01" @default.
• W3157158131 modified "2023-10-06" @default.
• W3157158131 title "Exploring Risks of Human Challenge Trials For COVID‐19" @default.
• W3157158131 cites W1517329556 @default.
• W3157158131 cites W1941946914 @default.
• W3157158131 cites W1976425076 @default.
• W3157158131 cites W1994815114 @default.
• W3157158131 cites W2032734720 @default.
• W3157158131 cites W2050238821 @default.
• W3157158131 cites W2090155117 @default.
• W3157158131 cites W2102409739 @default.
• W3157158131 cites W2170265923 @default.
• W3157158131 cites W2577537660 @default.
• W3157158131 cites W2793507472 @default.
• W3157158131 cites W2808888611 @default.
• W3157158131 cites W2889216941 @default.
• W3157158131 cites W2911837580 @default.
• W3157158131 cites W3025090814 @default.
• W3157158131 cites W3030938345 @default.
• W3157158131 cites W3037454632 @default.
• W3157158131 cites W3038225256 @default.
• W3157158131 cites W3041493976 @default.
• W3157158131 cites W3044231852 @default.
• W3157158131 cites W3047144258 @default.
• W3157158131 cites W3048737734 @default.
• W3157158131 cites W3079096948 @default.
• W3157158131 cites W3092140956 @default.
• W3157158131 cites W3092244835 @default.
• W3157158131 cites W3095683209 @default.
• W3157158131 cites W3128074129 @default.
• W3157158131 cites W3129524127 @default.
• W3157158131 cites W3132152828 @default.
• W3157158131 cites W4246039580 @default.
• W3157158131 cites W4255332681 @default.
• W3157158131 doi "https://doi.org/10.1111/risa.13726" @default.
• W3157158131 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8207107" @default.
• W3157158131 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33942351" @default.
• W3157158131 hasPublicationYear "2021" @default.
• W3157158131 type Work @default.
• W3157158131 sameAs 3157158131 @default.
• W3157158131 citedByCount "16" @default.
• W3157158131 countsByYear W31571581312021 @default.
• W3157158131 countsByYear W31571581312022 @default.
• W3157158131 countsByYear W31571581312023 @default.
• W3157158131 crossrefType "journal-article" @default.
• W3157158131 hasAuthorship W3157158131A5010975997 @default.
• W3157158131 hasAuthorship W3157158131A5038415036 @default.
• W3157158131 hasAuthorship W3157158131A5076793709 @default.
• W3157158131 hasAuthorship W3157158131A5087563394 @default.
• W3157158131 hasBestOaLocation W31571581311 @default.
• W3157158131 hasConcept C12174686 @default.
• W3157158131 hasConcept C126322002 @default.
• W3157158131 hasConcept C177713679 @default.
• W3157158131 hasConcept C187316915 @default.
• W3157158131 hasConcept C194828623 @default.
• W3157158131 hasConcept C2777288759 @default.
• W3157158131 hasConcept C2779134260 @default.
• W3157158131 hasConcept C2779473830 @default.
• W3157158131 hasConcept C2908647359 @default.
• W3157158131 hasConcept C3007834351 @default.
• W3157158131 hasConcept C3008058167 @default.
• W3157158131 hasConcept C38652104 @default.
• W3157158131 hasConcept C41008148 @default.
• W3157158131 hasConcept C44249647 @default.
• W3157158131 hasConcept C524204448 @default.
• W3157158131 hasConcept C535046627 @default.
• W3157158131 hasConcept C55493867 @default.
• W3157158131 hasConcept C71924100 @default.
• W3157158131 hasConcept C86803240 @default.
• W3157158131 hasConcept C99454951 @default.
• W3157158131 hasConceptScore W3157158131C12174686 @default.
• W3157158131 hasConceptScore W3157158131C126322002 @default.
• W3157158131 hasConceptScore W3157158131C177713679 @default.
• W3157158131 hasConceptScore W3157158131C187316915 @default.
• W3157158131 hasConceptScore W3157158131C194828623 @default.
• W3157158131 hasConceptScore W3157158131C2777288759 @default.
• W3157158131 hasConceptScore W3157158131C2779134260 @default.
• W3157158131 hasConceptScore W3157158131C2779473830 @default.
• W3157158131 hasConceptScore W3157158131C2908647359 @default.
• W3157158131 hasConceptScore W3157158131C3007834351 @default.
• W3157158131 hasConceptScore W3157158131C3008058167 @default.
• W3157158131 hasConceptScore W3157158131C38652104 @default.
• W3157158131 hasConceptScore W3157158131C41008148 @default.
• W3157158131 hasConceptScore W3157158131C44249647 @default.
• W3157158131 hasConceptScore W3157158131C524204448 @default.
• W3157158131 hasConceptScore W3157158131C535046627 @default.
• W3157158131 hasConceptScore W3157158131C55493867 @default.
• W3157158131 hasConceptScore W3157158131C71924100 @default.
• W3157158131 hasConceptScore W3157158131C86803240 @default.
• W3157158131 hasConceptScore W3157158131C99454951 @default.
• W3157158131 hasIssue "5" @default.
• W3157158131 hasLocation W31571581311 @default.

• next